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Formation of RuvABC—Holliday junction complexes in vitro
Adelina A. Davies and Stephen C. West
In Escherichia coli, the RuvA, RuvB and RuvC proteins
are required for the late stages of homologous
recombination and DNA repair [1]. RuvA and RuvB form
a complex that interacts with Holliday junctions —
crossed DNA structures that are recombination
intermediates — and promotes branch migration; RuvC
is a junction-specific endonuclease that resolves
Holliday junctions and completes the recombination
process. Because genetic and biochemical experiments
suggest that the processes of branch migration and
resolution are linked [2–7], coimmunoprecipitation
experiments were carried out to determine whether the
three Ruv proteins interact to form a functional complex
(RuvABC). Using a synthetic Holliday junction, a
multisubunit complex containing the junction and RuvA,
RuvB and RuvC was detected. In the absence of RuvB,
RuvAC—junction complexes were observed. Complex
formation was not facilitated by duplex DNA. The
identification of a RuvABC–junction complex provides
direct evidence that the RuvABC proteins interact at the
Holliday junction. 
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Results and discussion
To test whether RuvA, RuvB and RuvC form a distinct
multisubunit complex containing all three polypeptides,
interactions between the three purified proteins were
analysed. Monoclonal antibodies raised against each
protein were used to pull down complexes, which were
subsequently analysed by SDS–PAGE and western blot-
ting using a mixture of rabbit anti-RuvA, anti-RuvB and
anti-RuvC polyclonal antibodies.
In the absence of DNA, RuvA and RuvB formed a
complex that was immunoprecipitated by the anti-RuvA
(Figure 1a, lane 4) or the anti-RuvB (Figure 1b, lane 4)
monoclonal antibodies. This was expected because RuvA
and RuvB are known to interact in vitro [8,9]. RuvA–RuvC
interactions were not detected (Figure 1a, lane 7, and
Figure 1c, lane 4). Similarly, when RuvB and RuvC were
mixed, we failed to detect RuvC protein when immuno-
precipitating with the anti-RuvB monoclonal antibody
(Figure 1b, lane 7). Immunoprecipitation of RuvC by the
anti-RuvC antibody was found to be hindered by the pres-
ence of RuvB, however (Figure 1c, compare lanes 1 and
7). Because the two proteins aggregate in solution (A.H.
Mitchell, A.A.D. and S.C.W., unpublished observations)
and because RuvB was present in a fivefold molar excess
over RuvC, it is likely that most of the RuvC was associ-
ated with RuvB, forming aggregates that were inaccessible
to the anti-RuvC antibody. As expected, most of the RuvB
Figure 1
Coimmunoprecipitation of RuvABC. Combinations of the three Ruv
proteins (A, B and C) were incubated without DNA (–), with duplex
DNA (D) or with Holliday junction X0 DNA (X). Reactions (200 µl)
contained 50 mM Tris-acetate pH 8.0, 20 mM KOAc, 1 mM EDTA,
100 µg/ml bovine serum albumin (BSA; Sigma) and, where indicated,
DNA (100 nM). RuvA (250 nM) was incubated for 3 min at 37°C,
followed by RuvC (500 nM) for 5 min, and RuvB (2.5 µM) for a further
30 min. After incubation, 50 µl BSA (50 mg/ml) was added and
protein–DNA complexes were immunoprecipitated (IP) using 20 µg
(a) anti-RuvA, (b) anti-RuvB or (c) anti-RuvC monoclonal antibodies
coupled to protein-G–Sepharose beads (Pharmacia) using dimethyl
pimelimidate (Sigma). Complexes were analysed by SDS–PAGE
followed by western blotting with a mixture of rabbit anti-RuvA, anti-
RuvB and anti-RuvC polyclonal antibodies using enhanced
chemiluminescence (ECL) detection (Amersham). The polypeptide that
migrates between RuvA and RuvB is a degradation product of RuvB.
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was immunoprecipitated by the anti-RuvB antibody
(Figure 1b, lane 7). 
When interactions between all three proteins were exam-
ined, a RuvAB complex was detected when immunopre-
cipitating with either the anti-RuvA or the anti-RuvB
monoclonal antibodies (Figure 1a,b lane 10). RuvC was
not detected because immunoprecipitation of RuvC by
the RuvC monoclonal antibody was again inhibited by the
presence of RuvB (Figure 1c, compare lanes 1 and 10). We
conclude that RuvA and RuvB form a stable complex in
solution, but find no evidence for a RuvABC complex
under these conditions. 
Because a Holliday junction may provide a scaffold that
allows the assembly of a functional RuvABC complex,
immunoprecipitations were carried out in the presence of
DNA. A synthetic Holliday junction was prepared by
annealing four 60-mer oligonucleotides. The Holliday
junction (X0) used in this experiment contained an immo-
bile junction point and was resistant to cleavage by RuvC.
In the presence of junction X0, RuvA formed a complex
with RuvC that was immunoprecipitated with the anti-
RuvA (Figure 1a, lane 9) or the anti-RuvC (Figure 1c,
lane 6) monoclonal antibodies. When the junction was
replaced by duplex DNA, however, RuvA and RuvC
failed to coimmunoprecipitate (Figure 1a, lane 8 and
Figure 1c, lane 5). Using 32P-labelled junctions in the
immunoprecipitation experiments, we found that the
RuvA and RuvC proteins were indeed bound to DNA
(data not shown), confirming earlier findings that syn-
thetic Holliday junctions can be bound simultaneously by
RuvA and RuvC [5]. 
The identification of a RuvAC–junction complex is signif-
icant, as its formation might represent an important stage
in the transition between RuvAB-mediated branch migra-
tion and RuvC-mediated cleavage. Alternatively, the
structure could be part of a larger RuvABC–junction
complex. We therefore attempted to coimmunoprecipitate
RuvABC complexes with Holliday junction DNA.
Remarkably, we found that all three monoclonal antibod-
ies pulled down a complex containing RuvA, RuvB and
RuvC (Figure 1, lane 12 of panels a,b,c). When the junc-
tions were replaced by duplex DNA, RuvABC complexes
were not observed (Figure 1, lane 11 of panels a,b,c). 
Because it was possible that the immunoprecipitates con-
tained Holliday junction complexes consisting of a mixture
of RuvAB, RuvAC and RuvBC complexes rather than a
single complex comprising all three proteins, control experi-
ments were carried out to determine whether RuvBC com-
plexes could be immunoprecipitated in the absence of
RuvA. No evidence for the presence of a stable
RuvBC–Holliday junction complex was obtained
(Figure 1b,c, lane 9). These results provide the first physical
evidence for the existence of a specific RuvABC–Holliday
junction complex. 
In all of these experiments, each protein was added in a
predetermined order. In general, addition of RuvA to the
junction before RuvC produced complexes that were more
stable (Figure 2a, lanes 4–6), whereas addition of RuvC
before RuvA inhibited complex formation (Figure 2a, lanes
1–3). Complex formation was optimal when RuvB protein
was added last (Figure 2a, lane 5). The amount of RuvC in
the RuvABC complex detected in Figure 1 (lane 12) and
Figure 2a (lanes 4–6) appeared to be less than either RuvA
or RuvB. Controls in which equal amounts of the three
proteins were loaded onto a gel showed that RuvC was
poorly antigenic, however (Figure 2b). 
RuvC interacts specifically with Holliday junctions to
form a complex in which the DNA lies in a twofold sym-
metric open configuration [10]. In contrast, RuvA–junc-
tion complexes exhibit fourfold symmetry [11,12]. This
difference may explain why RuvA failed to form a
RuvAC–junction complex when the junction had been
prebound by RuvC, as RuvA may not be able to bind a
twofold symmetric RuvC–junction complex. These data
indicate that RuvA binding is required before RuvC to
impose fourfold symmetry on the junction; this structure
is subsequently bound by RuvC.
To determine whether the complex could be detected
under conditions in which the proteins were functionally
active, related experiments were carried out using a cleav-
able Holliday junction (X4) [7]. To favour Holliday junc-
tion resolution in the presence of limited branch migration,
the reaction buffer contained Mg2+ and a mixture of ATP
and ATPγS [7]. Control experiments, carried out in the
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Figure 2
(a) Dependence of RuvABC–junction complex formation on the order
of addition of the three proteins. The Ruv proteins were added in the
sequence indicated to reaction mixtures containing synthetic Holliday
junction DNA (X0). Protein complexes were analysed by
immunoprecipitation as described for Figure 1. (b) Sensitivity of the
western blotting assay. RuvA, RuvB and RuvC (25 ng each) were
separated by SDS–PAGE and detected by western blotting. 
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absence of Mg2+, ATP and ATPγS, confirmed that
RuvABC formed comparable complexes on either X4 or
X0 junctions (Figure 3b, lanes 1,3) and that neither junc-
tion was resolved under these conditions (Figure 3a, lanes
1,3). When Mg2+, ATP and ATPγS were included in the
reaction buffer, however, approximately 50% of junction
X4 was resolved into nicked duplex products (Figure 3a,
lane 4) and the amount of RuvABC–X4 complex was
reduced by approximately 50% (Figure 3b, lane 4) relative
to the inactive RuvABC–X4 complex (Figure 3b, lane 3).
The uncleavable X0 junction did not show this difference
(Figure 3b, lanes 1,2), indicating that the RuvABC
complex dissociates from the DNA upon resolution. 
Two models have been proposed to explain how branch
migration and resolution might be coordinated to allow
RuvC to be targeted to potential cleavage sites: firstly,
RuvAB may promote branch migration and dissociate at
DNA sequences that are suitable for cleavage by RuvC,
or, secondly, the RuvABC proteins may form a junction-
specific complex that is capable of both branch migration
and resolution [5,6,12–14]. The data presented here
provide direct evidence for the existence of a
RuvABC–Holliday junction complex and support the
second proposal. The precise nature and subunit composi-
tion of this complex remains to be elucidated.
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Figure 3
Dissociation of RuvABC–Holliday junction complexes. Reactions
(200 µl) contained junctions X0 or X4 (100 nM) as indicated (in
50 mM Tris-acetate pH 8.0, 20 mM KOAc, 100 µg/ml BSA) and the
RuvABC proteins, under conditions that either permitted (+) or
blocked (–) Holliday junction resolution. To permit junction resolution,
15 mM Mg(OAc)2, 1 mM ATP and 0.25 mM ATPγS (Mg2+ + NTP)
were added to the reactions; to block resolution, the Mg(OAc)2, ATP
and ATPγS were replaced by 1 mM EDTA. One strand of the DNA
junction was 32P-labelled at the 5′ end (20,000 cpm/nM). After 3 min
at 37°C with RuvA (250 nM), RuvC (500 nM) was added for 5 min,
and finally RuvB (2.5 µM) was added. After 30 min at 37°C, DNA was
deproteinised by addition of 20 µl stop buffer (100 mM Tris-HCl
pH 7.5, 20 mg/ml proteinase K, 5% SDS) followed by incubation for
10 min at 37°C. DNA products were analysed by 6% neutral PAGE
and (a) labelled DNA was visualised by autoradiography or
(b) protein–DNA complexes were analysed by immunoprecipitation, as
described for Figure 1. Branch migration (BM) products are indicated.
Junctions X0 and X4 were prepared by annealing four oligonucleotides
[7,15] and duplex DNA was prepared by annealing oligonucleotide 1
of X0 with its complementary strand [15]. DNA concentrations are
expressed in moles of junction.
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